These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
3. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease. Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135 [TBL] [Abstract][Full Text] [Related]
4. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease. Reddy PH; Oliver DM Cells; 2019 May; 8(5):. PubMed ID: 31121890 [TBL] [Abstract][Full Text] [Related]
5. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease. Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654 [TBL] [Abstract][Full Text] [Related]
6. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease. Bhatia V; Sharma S J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985 [TBL] [Abstract][Full Text] [Related]
7. Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review. Berlanga-Acosta J; Guillén-Nieto G; Rodríguez-Rodríguez N; Bringas-Vega ML; García-Del-Barco-Herrera D; Berlanga-Saez JO; García-Ojalvo A; Valdés-Sosa MJ; Valdés-Sosa PA Front Endocrinol (Lausanne); 2020; 11():560375. PubMed ID: 33224105 [TBL] [Abstract][Full Text] [Related]
8. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling. Rhein V; Eckert A Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309 [TBL] [Abstract][Full Text] [Related]
9. Cholesterol alters mitophagy by impairing optineurin recruitment and lysosomal clearance in Alzheimer's disease. Roca-Agujetas V; Barbero-Camps E; de Dios C; Podlesniy P; Abadin X; Morales A; Marí M; Trullàs R; Colell A Mol Neurodegener; 2021 Mar; 16(1):15. PubMed ID: 33685483 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease. Medala VK; Gollapelli B; Dewanjee S; Ogunmokun G; Kandimalla R; Vallamkondu J J Neurosci Res; 2021 Apr; 99(4):1120-1135. PubMed ID: 33465841 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease. Rai SN; Singh C; Singh A; Singh MP; Singh BK Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development. Bhatia S; Rawal R; Sharma P; Singh T; Singh M; Singh V Curr Neuropharmacol; 2022; 20(4):675-692. PubMed ID: 33998995 [TBL] [Abstract][Full Text] [Related]
13. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology. Akhtar A; Bishnoi M; Sah SP Brain Res Bull; 2020 Nov; 164():83-97. PubMed ID: 32784004 [TBL] [Abstract][Full Text] [Related]
14. Nrf2 activation through the PI3K/GSK-3 axis protects neuronal cells from Aβ-mediated oxidative and metabolic damage. Sotolongo K; Ghiso J; Rostagno A Alzheimers Res Ther; 2020 Jan; 12(1):13. PubMed ID: 31931869 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer's Disease: A Critical Review of New and Old Little Regarded Findings. Atlante A; Valenti D Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958934 [TBL] [Abstract][Full Text] [Related]
16. Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer's disease brain. Abolhassani N; Leon J; Sheng Z; Oka S; Hamasaki H; Iwaki T; Nakabeppu Y Mech Ageing Dev; 2017 Jan; 161(Pt A):95-104. PubMed ID: 27233446 [TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link. Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110 [TBL] [Abstract][Full Text] [Related]
18. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics. Di Domenico F; Barone E; Perluigi M; Butterfield DA Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216 [TBL] [Abstract][Full Text] [Related]
19. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease. Lynn J; Park M; Ogunwale C; Acquaah-Mensah GK J Alzheimers Dis; 2022; 85(2):485-501. PubMed ID: 34842187 [TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients. Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]